Found: 5
Select item for more details and to access through your institution.
Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.
- Published in:
- Nature Communications, 2016, v. 7, n. 2, p. 10703, doi. 10.1038/ncomms10703
- By:
- Publication type:
- Article
An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.
- Published in:
- Nature Communications, 2015, v. 6, n. 8, p. 7956, doi. 10.1038/ncomms8956
- By:
- Publication type:
- Article
Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00217-9
- By:
- Publication type:
- Article
Editorial Expression of Concern: birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy.
- Published in:
- NPJ Precision Oncology, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41698-018-0062-1
- By:
- Publication type:
- Article
Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15721-y
- By:
- Publication type:
- Article